Published in Cardiovascular Business Week, December 14th, 2004
The company reported that revenues for the 2004 third quarter and first 9 months decreased 21% and rose 1%, respectively, compared to revenues in the same periods last year.
The company recently announced that it closed a $6.0 million convertible financing facility from Laurus Master Fund, Ltd., chairman and CEO Michael J. Quinn commented, "The completion of this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.